Authors:
Waterhouse, DN
Dos Santos, N
Mayer, LD
Bally, MB
Citation: Dn. Waterhouse et al., Drug-drug interactions arising from the use of liposomal vincristine in combination with other anticancer drugs, PHARM RES, 18(9), 2001, pp. 1331-1335
Citation: M. Wong et al., Oxazole yellow homodimer YOYO-1-labeled DNA: a fluorescent complex that can be used to assess structural changes in DNA following formation and cellular delivery of cationic lipid DNA complexes, BBA-GEN SUB, 1527(1-2), 2001, pp. 61-72
Citation: Wm. Li et al., Enhanced immune response to T-independent antigen by using CpG oligodeoxynucleotides encapsulated in liposomes, VACCINE, 20(1-2), 2001, pp. 148-157
Citation: Gg. Chikh et al., Efficient delivery of antennapedia homeodomain fused to CTL epitope with liposomes into dendritic cells results in the activation of CD8(+) T cells, J IMMUNOL, 167(11), 2001, pp. 6462-6470
Citation: Q. Hu et al., Programmable fusogenic vesicles for intracellular delivery of antisense oligodeoxynucleotides: enhanced cellular uptake and biological effects, BBA-BIOMEMB, 1514(1), 2001, pp. 1-13
Citation: Wm. Li et al., Intermembrane transfer of polyethylene glycol-modified phosphatidylethanolamine as a means to reveal surface-associated binding ligands on liposomes, BBA-BIOMEMB, 1513(2), 2001, pp. 193-206
Authors:
Johnstone, SA
Masin, D
Mayer, L
Bally, MB
Citation: Sa. Johnstone et al., Surface-associated serum proteins inhibit the uptake of phosphatidylserineand poly(ethylene glycol) liposomes by mouse macrophages, BBA-BIOMEMB, 1513(1), 2001, pp. 25-37
Citation: Gnc. Chiu et al., Selective protein interactions with phosphatidylserine containing liposomes alter the steric stabilization properties of poly(ethylene glycol), BBA-BIOMEMB, 1510(1-2), 2001, pp. 56-69
Citation: Rj. Klasa et al., Eradication of human non-Hodgkin's lymphoma in SCID mice by BCL-2 antisense oligonucleotides combined with low-dose cyclophosphamide, CLIN CANC R, 6(6), 2000, pp. 2492-2500
Authors:
Lim, HJ
Parr, MJ
Masin, D
McIntosh, NL
Madden, TD
Zhang, GY
Johnstone, S
Bally, MB
Citation: Hj. Lim et al., Kupffer cells do not play a role in governing the efficacy of liposomal mitoxantrone used to treat a tumor model designed to assess drug delivery to liver, CLIN CANC R, 6(11), 2000, pp. 4449-4460
Authors:
Johnstone, SA
Gelmon, K
Mayer, LD
Hancock, RE
Bally, MB
Citation: Sa. Johnstone et al., In vitro characterization of the anticancer activity of membrane-active cationic peptides. I. Peptide-mediated cytotoxicity and peptide-enhanced cytotoxic activity of doxorubicin against wild-type and p-glycoprotein over-expressing tumor cell lines, ANTI-CAN DR, 15(2), 2000, pp. 151-160
Citation: Hj. Lim et al., Role of drug release and liposome-mediated drug delivery in governing the therapeutic activity of liposomal mitoxantrone used to treat human A431 andLS180 solid tumors, J PHARM EXP, 292(1), 2000, pp. 337-345
Citation: P. Harvie et al., Use of poly(ethylene glycol)-lipid conjugates to regulate the surface attributes and transfection activity of lipid-DNA particles, J PHARM SCI, 89(5), 2000, pp. 652-663
Authors:
Wasan, EK
Reimer, DL
Harvie, P
Kong, S
Wong, FMP
Bally, MB
Citation: Ek. Wasan et al., Targeted gene transfer - A practical guide based on experience with lipid-based plasmid delivery systems, METH MOL M, 25, 2000, pp. 255-304
Authors:
Adlakha-Hutcheon, G
Bally, MB
Shew, CR
Madden, TD
Citation: G. Adlakha-hutcheon et al., Controlled destabilization of a liposomal drug delivery system enhances mitoxantrone antitumor activity, NAT BIOTECH, 17(8), 1999, pp. 775-779
Citation: Dn. Saxon et al., Liposomal anticancer drugs as agents to be used in combination with other anticancer agents: Studies on a liposomal formulation with two encapsulateddrugs, J LIPOS RES, 9(4), 1999, pp. 507-522
Authors:
Reimer, DL
Kong, S
Monck, M
Wyles, J
Tam, P
Wasan, EK
Bally, MB
Citation: Dl. Reimer et al., Liposomal lipid and plasmid DNA delivery to B16/BL6 tumors after intraperitoneal administration of cationic liposome DNA aggregates, J PHARM EXP, 289(2), 1999, pp. 807-815
Citation: Ld. Mayer et al., Intravenous pretreatment with empty pH gradient liposomes alters the pharmacokinetics and toxicity of doxorubicin through in vivo active drug encapsulation, J PHARM SCI, 88(1), 1999, pp. 96-102
Authors:
Wasan, EK
Harvie, P
Edwards, K
Karlsson, G
Bally, MB
Citation: Ek. Wasan et al., A multi-step lipid mixing assay to model structural changes in cationic lipoplexes used for in vitro transfection, BBA-BIOMEMB, 1461(1), 1999, pp. 27-46
Citation: Fmp. Wong et al., Electrostatically mediated interactions between cationic lipid-DNA particles and an anionic surface, ARCH BIOCH, 366(1), 1999, pp. 31-39